2,000 AstraZeneca grant funds innovative Christiana Care cardiovascular outreach program
Image by Christiana Care
The AstraZeneca HealthCare Foundation awarded a grant of more than 2,000 to Christiana Care Health System’s Cardiovascular Outreach Prevention Program Tuesday, Feb. 14 (Valentine’s Day), at Paul M. Hodgson Vocational Technical High School in Newark. Learn more at Christiana Care News.astrazeneca
AstraZeneca slashing 1200 jobs in Delaware
AstraZeneca said Monday it is eliminating 1,200 positions at its Wilmington, Del., offices, which will remain as its North American headquarters. The changes are part of a global restructuring for the pharmaceutical company, which will have in new ... astrazeneca
Read more on Philadelphia Business Journal
The Outlook for AstraZeneca
ASTRAZENECA PLC: International Competitive Benchmarks and Financial Gap Analysis (Financial Performance Series)
Description :
astrazeneca
No Products Found...yet?
This is no time to give up. We'll search high and low for anything you dream of owning. Just enter a search below
Image by Christiana Care
The AstraZeneca HealthCare Foundation awarded a grant of more than 2,000 to Christiana Care Health System’s Cardiovascular Outreach Prevention Program Tuesday, Feb. 14 (Valentine’s Day), at Paul M. Hodgson Vocational Technical High School in Newark. Learn more at Christiana Care News.astrazeneca
AstraZeneca slashing 1200 jobs in Delaware
AstraZeneca said Monday it is eliminating 1,200 positions at its Wilmington, Del., offices, which will remain as its North American headquarters. The changes are part of a global restructuring for the pharmaceutical company, which will have in new ... astrazeneca
Read more on Philadelphia Business Journal
The Outlook for AstraZeneca
Maynard Paton discusses AstraZeneca's third-quarter results. Find out which three sectors our analysts favour at http://www.fool.co.uk/topsectors.astrazeneca
Video Rating: 0 / 5
ASTRAZENECA PLC: International Competitive Benchmarks and Financial Gap Analysis (Financial Performance Series)
Description :
astrazeneca
No comments:
Post a Comment